Archiwum hase³
Giant-cell tumor {GCT} (of the bone) | Tumor immune escape | Immune escape | dilated cardiomyopathy {DCM} | housekeeping genes {HKG} | Merkel cell carcinoma {MCC} | Total body irradiation {TBI} | Progression free survival {PFS} | forerunner genes {FG} | Disease-modifying anti-rheumatic drugs {DMARD} | Dose limiting toxicity {DLT} | Drug induced liver injury {DILI} | Castrate-resistant prostate cancer {CRPC} | Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 {PIMS} | orchiopexy | hypercapnia | Cervical intraepithelial neoplasia {CIN} | Cervical squamous intraepithelial lesions | Squamous intraepithelial lesion {SIL} | High squamous intraepithelial lesion {HSIL} | Intraepithelial lesion {IN} | low grade squamous epithelial lesion{LSIL}/ mild dysplasia, {CIN 1} | high grade squamous epithelial lesion {HSIL}/ moderate dysplasia {CIN2} | cocoon strategy of vaccinations | sink conditions | Postherapeutic neuralgia {PHN} | Resiliency | compensatory brain activity | neurocognitive plasticity | CRUNCH hypothesis - Compensation-Related Utilization of Neural Circuits Hypothesis {CRUNCH} | Prediabetes | Extracorporeal Shockwave Therapy {ESWT} | Non-alcoholic steatohepatitis {NASH} | Magnetic resonance elastography {MRE} | Descending necrotizing mediastinitis | diabetic kidney disease {DKD} | Xerostomia spuria | Drug delivery system {DDS} | Erythrocyte sedimentation rate {ESR} | hepatic stellate cells {HSC} | Mitochondrial voltage-dependent potassium channel {mitoKv1.3} | Mitochondrial potassium channel | Pore forming subunits | Mitochondrial ATP-regulated potassium channel {mitoKATP} | Renal outer medullary potassium channel {ROMK} | Renal outer medullary potassium {ROMK} | Thick ascending limb {TAL} | cortical collecting duct {CCD} | collecting duct {CD} | natriuresis | metabolic alkalosis | Delayed Sleep-Phase Syndrome {DSPS} | Neonatal ophthalmia | Dissociative fugue | Assembloid | Bovine Corneal Opacity and Permeability {BCOP} test | Hen's egg-chorioallantoic membrane test {HET-CAM} | Metabolic syndrome {MS} {MeS} | Cryopyrin-Associated Periodic Syndromes {CAPS} | Familial Cold Autoinflammatory Syndrome {FCAS} | Muckle-Wells Syndrome {MWS} | Chronic Infantile Neurologic Cutaneous Articular syndrome {CINCA} | Neonatal Onset Multi-systemic Inflammatory Disease {NOMID} | congestive heart failure disease {CHF} | congestive heart failure {CHF} | distal convoluted tubule {DCT} | hypokalemia | Intraepithelial limphocyte {IEL} | Sympathetic ophthalmia {SO} | myasthenia gravis | Severe Combined Immunodeficiency {SCID} | dilatation and curetage {D&C} | decongestant | enema | mitral annulus | Doppler tissue imaging {DTI} | Hyperviscosity syndrome {HVS} | free light chains {FLC} | osmotic controlled release oral delivery system {OROS} | Solid pseudopapillary neoplasms {SPN} | Islet-cell tumors | Cystitis cystica {CC} | Bladder Pain Syndrome | Obstructive sleep apnea syndrome {OSAS} | Atherogenic index of plasma {AIP} | Interstitial cystitis {IC} | minimal residual disease {MRD} | pulmonary capillary wedge pressure {PCWP} | death domain receptors | Necroptosis | programmed necrosis" or "" | acanthosis nigricans | genetic instability | adult asthma | Convection- enhanced delivery {CED} | Disinhibited Social Engagement Disorder {DSED} | autophagy | african sleeping sickness | autophagosome | mean corpuscular volume {MCV} | Myometrium | Uterine fibroids | Uterine Artery Embolisation {UAE} | Saline Infusion Sonography {SIS } | clinical flare | tumor flare | Conjugated equine estrogens {CEE} | selective progesterone receptor modulators {SPRM} | Vulvovaginal atrophy {VVA} | bone turnover | subsyndromal depression | endometrioma | gender reassignment | Generalized bullous fixed drug eruption (GBFDE) | laparoscopic myomectomy | microcytic anemia | add-back therapy | diet induced obesity {DIO} | supracervical hysterectomy | Bouchard's nodes | benign reccurent intrahepatic cholestasis (BRIC) | monochorionic twin gestation | maximal vertical pocket {MVP} | molecular docking | keratoconjunctivitis sicca | Plasma cell myeloma {PCM} | subclonal heterogeneity | bone marrow microenviroment | smoldering multiple myeloma {SMM} | somatic hypermutation {SHM} | class switch recombination {CSR} | Monoclonal gammopathy of undetermined significance {MGUS } | Mitogen-activated protein kinase {MAPK} | Hepatocyte growth factor {HGF} | Mammalian target of rapamycin kinase {mTOR} | comparative genomic hybridization {CGH} | genome-wide association study {GWAS} | Loss of heterozygosity {LOH} | monoclonal gammopathy of undetermined significance {MGUS} | Next generation sequencing {NGS} | Bed nucleus of the stria terminalis {BNST} | Frontotemporal dementia {FTD} | chronic wound | TIME (tissue, infection or inflammation, moisture, and edge) | linear IgA bullous dermatosis {LABD} | benign chronic bullous dermatosis of childhoo | Bedsore | electuary | Mohs micrographic surgery, | Rete Ridges | Polymicrogyria {PMG} | Tumour nest | Drug-induced liver injury {DILI} | idiosyncratic liver damage | Febrile neutropenia {FN} | Transitional cell carcinoma {TCC} | Carcinomatous meningitis | leptomeningeal carcinomatosis | drug hypersensitivity | triple negative breast cancer {TNBC} | Urothelial carcinoma | Isolated Limb Perfusion {ILP} | Osteochondrosis dissecans {OCD} | idiopathic hyper-CK-emia | Antiphospholipid syndrome {APS} | Primary antiphospholipid syndrome {PAPS} | Secondary antiphospholipid syndrome {SAPS} | Antyphospholipid antibodies {APLA} | Catastrophic antiphospholid syndrome {CAPS} | atypical haemolytic-uremic syndrome {aHUS} | paroxysmal nocturnal hemoglobinuria {PHN} | Sex Hormone Binding Globulin {SHBG} | central adiposity | varicocele | breakthrough infections | humoral immune response {HIR} | tenosynovitis | Circulating Tumor Cells {CTCs} | cell based therapy | mesenchymal stem cells {MSC} / mesenchymal stromal cells | induced-pluripotent stem cells {iPS} | human neural precursor cells {hNPC} | human embryonic stem cells {hESC} | human induced pluripotent stem {hiPS} | metachromatic leukodystrophy {MLD} | advanced therapy cell products {ATMP} | retinitis pigmentosa {RP} | Retinal Pigment Epithelium {RPE} | human umbilical vein endothelial cells {HUVEC} | Danon disease | Embryonic Stem Cells {ESC} | experimental autoimmune encephalomyelitis {EAE} | olfactory ensheathing cell {OEC} | Subventricular zone {SVZ} | immune surveillance | Immunosurveillance Theory | Intermittent treatment | Intermittent Catherization {IC} | fusion gene | Carcinoembryonic antigen {CEA} |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
